These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis. Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767 [TBL] [Abstract][Full Text] [Related]
4. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario. Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904 [TBL] [Abstract][Full Text] [Related]
5. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio. Hall PL; Wittenauer A; Hagar A Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677 [TBL] [Abstract][Full Text] [Related]
6. Newborn screening and genetic variation of medium chain acyl-CoA dehydrogenase deficiency in the Chinese population. Li YY; Xu J; Sun XC; Li HY; Mu K J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1264-1271. PubMed ID: 36068006 [TBL] [Abstract][Full Text] [Related]
7. Acylcarnitine profiles during carnitine loading and fasting tests in a Japanese patient with medium-chain acyl-CoA dehydrogenase deficiency. Yokoi K; Ito T; Maeda Y; Nakajima Y; Ueta A; Nomura T; Koyama N; Kato I; Suzuki S; Kurono Y; Sugiyama N; Togari H Tohoku J Exp Med; 2007 Dec; 213(4):351-9. PubMed ID: 18075239 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin. Van Calcar SC; Baker MW; Williams P; Jones SA; Xiong B; Thao MC; Lee S; Yang MK; Rice GM; Rhead W; Vockley J; Hoffman G; Durkin MS Mol Genet Metab; 2013; 110(1-2):111-5. PubMed ID: 23712021 [TBL] [Abstract][Full Text] [Related]
13. Dissection of biochemical borderline phenotypes in carriers and genetic variants of medium-chain acyl-CoA dehyrogenase deficiency: implications for newborn screening [corrected]. Maier EM; Pongratz J; Muntau AC; Liebl B; Nennstiel-Ratzel U; Busch U; Fingerhut R; Olgemöller B; Roscher AA; Röschinger W Clin Genet; 2009 Aug; 76(2):179-87. PubMed ID: 19780764 [TBL] [Abstract][Full Text] [Related]
14. Selective Screening of Fatty Acids Oxidation Defects and Organic Acidemias by Liquid Chromatography/tandem Mass Spectrometry Acylcarnitine Analysis in Brazilian Patients. Vargas CR; Ribas GS; da Silva JM; Sitta A; Deon M; de Moura Coelho D; Wajner M Arch Med Res; 2018 Apr; 49(3):205-212. PubMed ID: 30119976 [TBL] [Abstract][Full Text] [Related]
15. Clinical, biochemical and genetic analyses in two Korean patients with medium-chain acyl-CoA dehydrogenase deficiency. Woo HI; Park HD; Lee YW; Lee DH; Ki CS; Lee SY; Kim JW Korean J Lab Med; 2011 Jan; 31(1):54-60. PubMed ID: 21239873 [TBL] [Abstract][Full Text] [Related]
16. A nationwide retrospective observational study of population newborn screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in the Netherlands. Jager EA; Kuijpers MM; Bosch AM; Mulder MF; Gozalbo ER; Visser G; de Vries M; Williams M; Waterham HR; van Spronsen FJ; Schielen PCJI; Derks TGJ J Inherit Metab Dis; 2019 Sep; 42(5):890-897. PubMed ID: 31012112 [TBL] [Abstract][Full Text] [Related]
17. Medium-chain acyl-CoA dehydrogenase deficiency in Saudi Arabia: incidence, genotype, and preventive implications. Al-Hassnan ZN; Imtiaz F; Al-Amoudi M; Rahbeeni Z; Al-Sayed M; Al-Owain M; Al-Zaidan H; Al-Odaib A; Rashed MS J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S263-7. PubMed ID: 20567907 [TBL] [Abstract][Full Text] [Related]